Novel Therapeutic Approach for the Treatment of Alzheimer’s Disease by Peripheral Administration of Agents with an Affinity to -Amyloid
نویسندگان
چکیده
Yasuji Matsuoka,1,2 Mitsuo Saito,1,2 John LaFrancois,1 Mariko Saito,1,2 Kate Gaynor,1 Vicki Olm,1 Lili Wang,1 Evelyn Casey,1 Yifan Lu,1 Chiharu Shiratori,1 Cynthia Lemere,3 and Karen Duff 1,2 1The Center for Dementia Research, Nathan Kline Institute, Orangeburg, New York 10962, 2New York University School of Medicine, New York, New York 10016, and 3Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115
منابع مشابه
The effects of chronic administration of pioglitazone on learning and memory in streptoztocin rat model of Alzheimer’s disease
Background: Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterized by abnormal protein accumulation, synaptic dysfunction, and cognitive impairment. Peroxisome proliferator-activated gamma receptors (PPARγ) play a crucial role in regulating insulin sensitivity and may serve as potential therapeutic targets for AD. Pioglitazone (Piog) as a PPARγ agonist reduce β-amyloid ...
متن کاملEllagic acid attenuates enhanced acetylcholinesterase reactivity in an experimental model of Alzheimer′s disease induced by beta amyloid25-35 in the rat
Background and Objective: Alzheimer’s disease (AD) is a multifactorial disease with debilitating consequences and few therapeutic strategies exist for it. With regard to antioxidant capacity and anti-β-amyloid polymerization potential of ellagic acid, this study was conducted to evaluate the effect of this substance on enhanced acetylcholinesterase reactivity in an experimental model of Alzheim...
متن کاملVitamin E therapy prevents the accumulation of congophilic amyloid plaques and neurofibrillary tangles in the hippocampus in a rat model of Alzheimer’s disease
Objective(s): Vitamin E may have beneficial effects on oxidative stress and Aβ-associated reactive oxygen species production in Alzheimer’s disease. But, the exact role of vitamin E as a treatment for Alzheimer’s disease pathogenesis still needs to be studied. Hence, we examined the therapeutic effects of vitamin E on the density of congophilic amyloid plaques and neur...
متن کاملNeuroprotective effects of epigallocatechin-3-gallate in an experimental model of Alzheimer’s disease in rat: a histological study
Abstract Introduction: Neurodegeneration change is one of the hallmark symptoms of which Alzheimer’s disease (AD) can be modeled by β-amyloid injection into specific regions of brain. (-)-Epigallocatechin-3-gallate (EGCG) is a potent antioxidant agent that its role against oxidative stress and inflammation has been shown in prior studies. In the present study, we have wanted to determine wh...
متن کاملNovel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid.
Plaques containing beta-amyloid (Abeta) peptides are one of the pathological features of Alzheimer's disease, and the reduction of Abeta is considered a primary therapeutic target. Amyloid clearance by anti-Abeta antibodies has been reported after immunization, and recent data have shown that the antibodies may act as a peripheral sink for Abeta, thus altering the periphery/brain dynamics. Here...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2002